Vanguard Group reports zero Amgen (AMGN) holdings after internal realignment

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 11 on a Schedule 13G/A reporting 0 shares of Amgen Inc. common stock. The filing states that, following an internal realignment on 01/12/2026, certain Vanguard subsidiaries now report beneficial ownership separately pursuant to SEC Release No. 34-39538 (01/12/1998), and The Vanguard Group no longer is deemed to beneficially own securities held by those subsidiaries. The amendment lists Amount beneficially owned: 0 and Percent of class: 0%, with all voting and dispositive powers shown as 0.

Insights

Institutional Ownership Analyst

Vanguard disaggregated holdings and reports zero beneficial ownership for Amgen.

The amendment shows Amount beneficially owned: 0 and Percent of class: 0% as of the filing. It attributes this change to an internal realignment on 01/12/2026 and reliance on SEC Release No. 34-39538 (01/12/1998).

Cash‑flow treatment or which subsidiaries now report separately is timing and scope information not included in the excerpt; subsequent filings by Vanguard’s subsidiaries may disclose the separate beneficial ownership balances.

Corporate Governance Specialist

The filing documents a reporting structure change, not an economic disposition of Amgen shares.

The Vanguard Group states it no longer is "deemed to have" beneficial ownership over securities held by restructured subsidiaries, which is a compliance/administrative reporting change tied to SEC Release No. 34-39538.

Investors should note this is a disclosure of reporting allocation; the excerpt lists all voting and dispositive powers as 0 and does not state any share transfers or sales.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 11)

Amgen Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

(CUSIP Number)

03/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Amgen Inc
(b)	Address of issuer's principal executive offices: 1 Amgen Center Drive, Thousand Oaks, CA, 91320
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd.,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	03/26/2026

FAQ

What does The Vanguard Group report for AMGN ownership?

The Vanguard Group reports 0 shares and 0% beneficial ownership of Amgen common stock. The filing states all voting and dispositive powers are shown as 0, reflecting a reporting allocation change after internal reorganization.

Why did Vanguard report zero ownership on the Schedule 13G/A for AMGN?

Vanguard reports zero because of an internal realignment completed on 01/12/2026. The filing cites SEC Release No. 34-39538 (01/12/1998) and says subsidiaries now report ownership separately from The Vanguard Group.

Does the amendment indicate Vanguard sold Amgen shares?

No, the amendment does not state any sale or transfer of shares. It attributes the change to disaggregated reporting under a regulatory release rather than describing economic dispositions.

Which Vanguard entity signed the Amendment No. 11 for AMGN?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, on 03/26/2026. The filing lists The Vanguard Group with its Malvern, PA address as the reporting person.

Does the filing show any voting or dispositive power for Vanguard in AMGN?

No, the filing lists sole and shared voting power and sole and shared dispositive power each as 0. The Schedule 13G/A shows no control or disposition authority by The Vanguard Group.